Health AI Central
Peer-Reviewed Publication
Drug Discov Today2024;29(8):104058.August 1, 2024Editorial

50 shades of AI in regulatory science.

Weida Tong1, Szczepan W Baran2
1National Center for Toxicological Research, Food and Drug Administration, Jefferson, AR 72079, United States.
2Verisim Life Inc., 1 Sansome Street, Suite 3500, San Francisco, CA 94104, United States. Electronic address: szczepan.baran@verisimlife.com.
PubMed PMC DOI PDF

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.